Yahoo Web Search

Search results

      • Valuation metrics show that Agios Pharmaceuticals, Inc. may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of AGIO, demonstrate its potential to underperform the market. It currently has a Growth Score of F.
      www.zacks.com › stock › research
  1. People also ask

  2. Jun 18, 2024 · Should I buy Agios Pharmaceuticals (AGIO)? Use the Zacks Rank and Style Scores to find out is AGIO is right for your portfolio.

  3. 1 day ago · In this article: AGIO. Agios Pharmaceuticals AGIO shares soared 6.5% in the last trading session to close at $45.22. The move was backed by solid volume with far more shares changing hands than in ...

  4. 1 day ago · Should I buy or sell Agios Pharmaceuticals stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Agios Pharmaceuticals in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock.

    • (617) 649-8600
    • 88 SIDNEY STREET, CAMBRIDGE MA, 02139
    • investors@agios.com
  5. 4 days ago · See the latest Agios Pharmaceuticals Inc stock price (AGIO:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

    • 12.84
    • 11.64
  6. Find the latest Agios Pharmaceuticals, Inc. (AGIO) stock quote, history, news and other vital information to help you with your stock trading and investing.

  7. 4 days ago · Is Agios Pharmaceuticals, Inc. (AGIO) a buy, sell, or hold? 8 analysts have issued ratings. Wall Street analysts rate AGIO as Bullish on average, for a Wall Street consensus of buy.

  8. May 3, 2020 · According to 5 analysts, the average rating for AGIO stock is "Buy." The 12-month stock price forecast is $48.5, which is an increase of 7.25% from the latest price.

  1. People also search for